-+ 0.00%
-+ 0.00%
-+ 0.00%

Akari Therapeutics to present PH1 ADC payload platform at oncology and investor conferences

PUBT·09/08/2026 13:15:51
Listen to the news
Akari Therapeutics to present PH1 ADC payload platform at oncology and investor conferences
  • Akari will present its PH1 ADC payload platform at conferences in September 2026 across the U.S. and China.
  • CEO Abizer Gaslightwala speaks at the Oncology & Immunology Innovation Partnering & Licensing Summit in Boston on Sept. 9-10.
  • Management joins the H.C. Wainwright Global Investment Conference in New York on Sept. 14-16.
  • Gaslightwala delivers a keynote at BioCon China in Shanghai on Sept. 15-16.
  • Akari also presents at the Global XDC Innovation Conference in WuXi on Sept. 17-19, then holds investor meetings at ROTH’s conference in New York on Sept. 29.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609080915PRIMZONEFULLFEED9822744) on September 08, 2026, and is solely responsible for the information contained therein.